PET and functional anatomic fusion imaging in lung and breast cancers

Cancer J. Jul-Aug 2004;10(4):251-61. doi: 10.1097/00130404-200407000-00006.

Abstract

Metabolic imaging with PET is an established adjunct to anatomic imaging methods in patients with bronchial and breast cancers. The functional anatomic fusion imaging with PET/CT can further improve staging and restaging of patients. PET/CT can influence the planning of a surgical intervention or radiation treatment at staging and in patients with suspected locoregional recurrence. The use of a PET/CT whole body imaging protocol may identify extended disease earlier than conventional imaging methods and thus influence treatment decisions.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / metabolism
  • Fluorodeoxyglucose F18*
  • Humans
  • Image Processing, Computer-Assisted
  • Lung Neoplasms / diagnostic imaging*
  • Lung Neoplasms / metabolism
  • Neoplasm Staging
  • Positron-Emission Tomography*
  • Radiographic Image Enhancement
  • Radiopharmaceuticals*

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18